Unknown

Dataset Information

0

Local delivery of mesenchymal stem cells with poly-lactic-co-glycolic acid nano-fiber scaffold suppress arthritis in rats.


ABSTRACT: Mesenchymal stem cells (MSC) have been used recently for the treatment of autoimmune diseases in murine animal models due to the immunoregulatory capacity. Current utilization of MSC requires cells in certain quantity with multiple courses of administration, leading to limitation in clinical usage. Here we efficiently treated collagen-induced arthritis rats with a single local implantation with reduced number of MSC (2?20% of previous studies) with nano-fiber poly-lactic-co-glycolic acid (nano-fiber) scaffold. MSC seeded on nano-fiber scaffold suppressed arthritis and bone destruction due to inhibition of systemic inflammatory reaction and immune response by suppressing T cell proliferation and reducing anti- type II collagen antibody production. In vivo tracing of MSC demonstrated that these cells remained within the scaffold without migrating to other organs. Meanwhile, in vitro culture of MSC with nano-fiber scaffold significantly increased TGF-?1 production. These results indicate an efficient utilization of MSC with the scaffold for destructive joints in rheumatoid arthritis by a single and local inoculation. Thus, our data may serve as a new strategy for MSC-based therapy in inflammatory diseases and an alternative delivery method for bone destruction treatment.

SUBMITTER: Zhang X 

PROVIDER: S-EPMC4256456 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

Local delivery of mesenchymal stem cells with poly-lactic-co-glycolic acid nano-fiber scaffold suppress arthritis in rats.

Zhang Xiangmei X   Yamaoka Kunihiro K   Sonomoto Koshiro K   Kaneko Hiroaki H   Satake Makoto M   Yamamoto Yuka Y   Kondo Masahiro M   Zhao Jidong J   Miyagawa Ippei I   Yamagata Kaoru K   Fukuyo Shunsuke S   Okada Yosuke Y   Tanaka Yoshiya Y  

PloS one 20141204 12


Mesenchymal stem cells (MSC) have been used recently for the treatment of autoimmune diseases in murine animal models due to the immunoregulatory capacity. Current utilization of MSC requires cells in certain quantity with multiple courses of administration, leading to limitation in clinical usage. Here we efficiently treated collagen-induced arthritis rats with a single local implantation with reduced number of MSC (2∼20% of previous studies) with nano-fiber poly-lactic-co-glycolic acid (nano-f  ...[more]

Similar Datasets

| S-EPMC7411994 | biostudies-literature
| S-EPMC2605109 | biostudies-literature
| S-EPMC7203963 | biostudies-literature
| S-EPMC7475521 | biostudies-literature
| S-EPMC2653259 | biostudies-other
| S-EPMC4908658 | biostudies-other
| S-EPMC5642922 | biostudies-literature